Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-22-035864
Date:2022-06-09
Issuer: REGULUS THERAPEUTICS INC. (RGLS)
Original Submission Date:

Reporting Person:

SIMEONIDIS SIMOS
C/O REGULUS THERAPEUTICS
4224 CAMPUS POINT COURT #210 SAN DIEGO, CA 92121

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 0.27 2022-06-09 deemed execution date A 90,000 (a) 2032-06-09 common stock 90,000 $0.27 90,000 direct
Footnotes
IDfootnote
f1 pursuant to the company's non employee director's compensation policy, the options are automatically granted on the date of the company's annual meeting of stockholders and will vest ratably over the following twelve months such that the option will be fully vested one year after the date of grant or on the date of the company's next annual stockholder meeting, whichever occurs first, subject to the reporting person's continuous service.
WhaleWisdom Logo

Elevate your investments